Interestingly, the basal-like and human epidermal growth factor receptor 2 (HER2)-enriched intrinsic breast cancer subtypes were significantly associated with the inflammatory heterocellular subtype (Fig. 1d and Supplementary Table 1e–g), suggesting increased immune phenotype in these subtypes. Here, ERBB2 is linked to breast carcinoma.